The US Patent and Trademark Office (USPTO) is navigating a period of significant transition. Driven by workforce shifts, operational restructuring, evolving approaches to subject matter eligibility, a...
Whether you are in-house, outside counsel, a solo practitioner, or working alongside any of these teams, you should be aware of the duty to use artificial intelligence (AI) responsibly, ethically, and...
An article by Maria Crusey and Ed Russavage titled “Procedural Implications of Multidistrict AI Copyright Infringement Lawsuits” was published in Managing IP. As of November 21 2025, more than 50 laws...
In the United States, medical device regulation and intellectual property (IP) protection are governed by complex statutory and regulatory frameworks that are distinct from—but closely related to, and...
In the United States, medical device regulation and intellectual property (IP) protection are governed by complex statutory and regulatory frameworks that are distinct from—but closely related to, and...
An article by Nathan Jacobs titled “Clades, Classifications, and Claims: Evolution of Organisms and Their Nomenclature in Life Science Patents” was published in the Journal of Law and the Biosciences....
A column authored by Jason Balich titled “Discretion Takes Back Control at the PTAB” was published in the American Institute of Chemical Engineers’ Chemical Engineering Progress (CEP) Magazine. In thi...
(as published in IPWatchdog) Breakthroughs in artificial intelligence (AI) and quantum computing are being announced at a rapid pace. At the same time, we’re seeing more and more legal disputes relate...
As your company grows, expands, and develops new technology, it is critical to evaluate your intellectual property strategy. What may have worked during the early stages or for your initial technology...
The Trump administration recently announced that it will begin investigating compliance with the Bayh-Dole Act, signaling it may invoke march-in rights or more dramatic request for title of patents re...
Reissue applications represent a very small fraction of the total number of applications filed at the USPTO each year. Indeed, at the midpoint of 2025, over 1.2 million utility applications have been ...
Reissue applications represent a very small fraction of the total number of applications filed at the USPTO each year. Indeed, at the midpoint of 2025, over 1.2 million utility applications have been ...